Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
Lilian Varricchio, Camelia Iancu‐Rubin, Bhaskar Upadhyaya, et al.
JCI Insight (2021) Vol. 6, Iss. 18
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 252
TGF-beta signal transduction: biology, function and therapy for diseases
Yan Tie, Fan Tang, Dandan Peng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 68
Reviewing the Regulators of COL1A1
Hanne Devos, Jérôme Zoidakis, Maria G. Roubelakis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10004-10004
Open Access | Times Cited: 40
TGFβ signaling pathways in human health and disease
Pei‐Yu Chen, Lingfeng Qin, Michael Simons
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 38
Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
Ning Shi, Zhihong Wang, Hecheng Zhu, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 276-288
Open Access | Times Cited: 37
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Max Kam‐Kwan Chan, Emily Lok-Yiu Chan, Zoey Zeyuan Ji, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 316-343
Open Access | Times Cited: 19
Extracellular matrix remodeling facilitates obesity-associated cancer progression
Min Gyu Kim, Changhu Lee, Jiyoung Park
Trends in Cell Biology (2022) Vol. 32, Iss. 10, pp. 825-834
Closed Access | Times Cited: 24
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis
John Mascarenhas, Anna Ritá Migliaccio, Heidi E. Kosiorek, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 18, pp. 3622-3632
Open Access | Times Cited: 16
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation
Wenjuan Fan, Weijie Cao, Jianxiang Shi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1745-1759
Open Access | Times Cited: 13
TGF-β-Based Therapies for Treating Ocular Surface Disorders
Fernando T. Ogata, Sudhir Kumar Verma, Vivien J. Coulson‐Thomas, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1105-1105
Open Access | Times Cited: 4
Folate metabolism in myelofibrosis: a missing key?
Giacomo Maria Cerreto, Giulia Pozzi, Samuele Cortellazzi, et al.
Annals of Hematology (2025)
Open Access
Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Khursheed Ahmad Sheikh, Momna Amjad, Mohammad Irfan, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 233-262
Open Access
Structures of TGF-β with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling
Łukasz Wieteska, A.B. Taylor, Emma K. Punch, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
Giuseppe Gaetano Loscocco, Paola Guglielmelli
American Journal of Hematology (2025)
Open Access
Thrombocytopenia in Patients With Myelofibrosis: Pathogenesis, Prevalence, Prognostic Impact, and Treatment
Dahniel Sastow, John Mascarenhas, Douglas Tremblay
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 7, pp. e507-e520
Closed Access | Times Cited: 13
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1low Mice
Paola Verachi, Francesca Gobbo, Fabrizio Martelli, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Dual drug delivery collagen vehicles for modulation of skin fibrosis in vitro
João Q. Coentro, Alessia Di Nubila, Ulrike May, et al.
Biomedical Materials (2022) Vol. 17, Iss. 2, pp. 025017-025017
Open Access | Times Cited: 13
Recent advances in therapies for primary myelofibrosis
William Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Faculty Reviews (2023) Vol. 12
Open Access | Times Cited: 7
Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis
Lilian Varricchio, Ronald Hoffman
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects
Kiwon Lee, Hyun Sook Ahn, Brian Estevez, et al.
Blood (2022) Vol. 141, Iss. 3, pp. 260-270
Open Access | Times Cited: 11
Endothelial LATS2 is a suppressor of bone marrow fibrosis
Kishor K. Sivaraj, Paul-Georg Majev, Backialakshmi Dharmalingam, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 8, pp. 951-969
Open Access | Times Cited: 2
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
Yulia Vugmeyster, Ana‐Marija Grišić, Justin Wilkins, et al.
Cancer Chemotherapy and Pharmacology (2022) Vol. 90, Iss. 4, pp. 369-379
Open Access | Times Cited: 11
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice
Christophe Willekens, Lucie Laplane, Tracy Dagher, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1287-1297
Open Access | Times Cited: 6
Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice
Maria Zingariello, Paola Verachi, Francesca Gobbo, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 234-234
Open Access | Times Cited: 9
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis
Sara Lecomte, Julien Devreux, Grégoire de Streel, et al.
Blood (2022) Vol. 141, Iss. 5, pp. 490-502
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top